Posts in category Healthcare


H.C. Wainwright Dives In on Amarin Corporation plc (ADR) (AMRN) as REDUCE-IT Topline Data Within Sight

As REDUCE-IT continues to track to expected read-outs in early 2018, H.C. Wainwright analyst Andrew Fein …

Read more

Roth Capital Pounds The Table On Palatin Technologies, Inc. (PTN)

Roth Capital analyst Michael Higgins was out pounding the table on shares of Palatin Technologies, Inc. …

Read more

Roth Capital Raises Price Target for Synergy Pharmaceuticals Inc

Late last week, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the FDA approval of its lead drug …

Read more

BTIG Weighs In on Ocular Therapeutix Inc (OCUL) Following NDA Resubmission

This morning, Ocular Therapeutix Inc (NASDAQ:OCUL) announced the resubmission of a New Drug Application (NDA) …

Read more

BTIG Sets Expectations on Synergy Pharmaceuticals Inc (SGYP) Following FDA Approval

BTIG analyst Tim Chiang weighed in today on Synergy Pharmaceuticals Inc (NASDAQ:SGYP), after the drug maker reported …

Read more

Oppenheimer Chimes In On Synergy Pharmaceuticals Inc (SGYP) As Trulance Launch Expected In The Coming Weeks

Yesterday after the close, the FDA granted final approval to Synergy Pharmaceuticals Inc’s (NASDAQ:SGYP) Trulance …

Read more

FBR Optimistic on Novavax, Inc. (NVAX) Following Management Meeting

FBR analyst Vernon Bernardino met with Novavax, Inc. (NASDAQ:NVAX) management last week to discuss fundamentals and …

Read more

Needham Divided On Two Biotech Players: Gilead Sciences, Inc. (GILD), ACADIA Pharmaceuticals Inc. (ACAD)

Needham analyst Alan Carr is out with a mixed research report today on biotech players …

Read more

Synergy Pharmaceuticals Inc (SGYP) Shares Fall on Back of ‘Sell on the News’ Reaction; Rodman & Renshaw Bullish

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) impressed Rodman & Renshaw analyst Ram Selvaraju with the announcement yesterday …

Read more

William Blair Bullish on Synthetic Biologics Inc (SYN) on Back of FDA Phase IIb/III Trial Design Approval

Synthetic Biologics Inc (NYSEMKT:SYN) revealed Wednesday, January 18th after market close that the FDA has …

Read more